MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ:TTPY) announced today that it has partnered with Medical Intelligence, an Elekta company, to enhance the TomoTherapy® Hi·Art® treatment system’s stereotactic radiosurgery capabilities. A head frame fixation and repositioning device, is on display in the TomoTherapy booth at the Annual Meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO), which opened Sunday and runs through Wednesday, October 31, 2007. This is a works-in-progress prototype of the first product to be developed through the partnership.
